SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-125147
Filing Date
2024-04-30
Accepted
2024-04-30 16:16:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d774808d424b3.htm 424B3 150267
2 GRAPHIC g774808g08l03.jpg GRAPHIC 28909
3 GRAPHIC g774808g47r84.jpg GRAPHIC 41618
  Complete submission text file 0001193125-24-125147.txt   248658
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-278801 | Film No.: 24897472
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)